Toplantı Özeti


DOI :10.26650/JARHS2021-1133643   IUP :10.26650/JARHS2021-1133643    Tam Metin (PDF)

EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT

Ömer Küçük

Soy intake has been associated with a lower risk of prostate cancer. Soybeans contain isoflavones, genistein, daidzein and glycitein, which have shown anti-cancer effects in cell culture and animal studies. Recently clinical trials of soy isoflavones in humans have also shown promising results. Soy isoflavones have anti-oxidant and anti-inflammatory properties which may be important for their anticancer effects. In addition, recent studies have shown significant epigenetic effects of soy isoflavones. DNA methylation and histone acetylation has been reported to be modified by genistein. Therefore, genistein may have effects similar to the commonly used cancer drugs, demethylating agent 5-azacytidine and histone deacetylase inhibitor drug Vorinostat. Thus, combining genistein with cancer chemotherapeutic agents may have potential benefits. Furthermore, radiation therapy and conventional cancer therapeutic agents activate NF-kappa-B resulting in resistance to chemotherapy and radiation. Genistein is a potent inhibitor of NF-kappa-B, and thereby may sensitize cancer cells to chemotherapy and radiation therapy. While sensitizing cancer cells chemotherapy and radiation, at the same time genistein may protect the normal tissues from adverse effects of radiation chemotherapy which are due to their oxidative and inflammatory effects. Clinical trials investigating the chemotherapy and radiation therapy potentiating as well as toxicity reducing effects of soy isoflavones are warranted. In addition, adverse effects of androgen deprivation therapy, such as metabolic syndrome, hypertension, diabetes and cardiovascular disease could also be potentially prevented by soy isoflavones. 


PDF Görünüm

Referanslar

    Atıflar

    Biçimlendirilmiş bir atıfı kopyalayıp yapıştırın veya seçtiğiniz biçimde dışa aktarmak için seçeneklerden birini kullanın


    DIŞA AKTAR



    APA

    Küçük, Ö. (2022). EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT. Sağlık Bilimlerinde İleri Araştırmalar Dergisi, 5(1), 19-19. https://doi.org/10.26650/JARHS2021-1133643


    AMA

    Küçük Ö. EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT. Sağlık Bilimlerinde İleri Araştırmalar Dergisi. 2022;5(1):19-19. https://doi.org/10.26650/JARHS2021-1133643


    ABNT

    Küçük, Ö. EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT. Sağlık Bilimlerinde İleri Araştırmalar Dergisi, [Publisher Location], v. 5, n. 1, p. 19-19, 2022.


    Chicago: Author-Date Style

    Küçük, Ömer,. 2022. “EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT.” Sağlık Bilimlerinde İleri Araştırmalar Dergisi 5, no. 1: 19-19. https://doi.org/10.26650/JARHS2021-1133643


    Chicago: Humanities Style

    Küçük, Ömer,. EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT.” Sağlık Bilimlerinde İleri Araştırmalar Dergisi 5, no. 1 (Dec. 2022): 19-19. https://doi.org/10.26650/JARHS2021-1133643


    Harvard: Australian Style

    Küçük, Ö 2022, 'EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT', Sağlık Bilimlerinde İleri Araştırmalar Dergisi, vol. 5, no. 1, pp. 19-19, viewed 5 Dec. 2022, https://doi.org/10.26650/JARHS2021-1133643


    Harvard: Author-Date Style

    Küçük, Ö. (2022) ‘EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT’, Sağlık Bilimlerinde İleri Araştırmalar Dergisi, 5(1), pp. 19-19. https://doi.org/10.26650/JARHS2021-1133643 (5 Dec. 2022).


    MLA

    Küçük, Ömer,. EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT.” Sağlık Bilimlerinde İleri Araştırmalar Dergisi, vol. 5, no. 1, 2022, pp. 19-19. [Database Container], https://doi.org/10.26650/JARHS2021-1133643


    Vancouver

    Küçük Ö. EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT. Sağlık Bilimlerinde İleri Araştırmalar Dergisi [Internet]. 5 Dec. 2022 [cited 5 Dec. 2022];5(1):19-19. Available from: https://doi.org/10.26650/JARHS2021-1133643 doi: 10.26650/JARHS2021-1133643


    ISNAD

    Küçük, Ömer. EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT”. Sağlık Bilimlerinde İleri Araştırmalar Dergisi 5/1 (Dec. 2022): 19-19. https://doi.org/10.26650/JARHS2021-1133643



    ZAMAN ÇİZELGESİ


    Çevrimiçi Yayınlanma09.08.2022

    LİSANS


    Attribution-NonCommercial (CC BY-NC)

    This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


    PAYLAŞ




    İstanbul Üniversitesi Yayınları, uluslararası yayıncılık standartları ve etiğine uygun olarak, yüksek kalitede bilimsel dergi ve kitapların yayınlanmasıyla giderek artan bilimsel bilginin yayılmasına katkıda bulunmayı amaçlamaktadır. İstanbul Üniversitesi Yayınları açık erişimli, ticari olmayan, bilimsel yayıncılığı takip etmektedir.